Reckitt Benckiser Group plc (RBGLY) Stock Price & Analysis
Reckitt Benckiser Group plc (RBGLY) — price $14.71 (-2.84%), as of the Nov 19, 2026 trading session; market cap $46.6B.
Educational signal · not a buy or sell recommendation · How to read this
Reckitt Benckiser Group plc · RBGLY · Consumer Defensive · Household & Personal Products
Reckitt Benckiser Group Plc engages in the manufacture and trade of consumer brand products including Air Wick, Calgon, Cillit Bang, Clearasil, Dettol, Durex, Enfamil, Finish, Gaviscon, Harpic, Lysol, Mortein, Mucinex, Nurofen, Nutramigen,…
Price as of Nov 19, 2026
Key Statistics
No MoonshotScore yet: we have not published a score for this company.
Price & valuation
| Measure | Value | As of |
|---|---|---|
| Latest provided price | $14.71 | |
| Change on the day | -2.84% | |
| 52-week range | $12.02–$17.80 | |
| Market capitalisation | $46.6B | — |
| Price / earnings (trailing) | 12.87 | |
| Shares traded on the day | 126.5K | |
| Beta (volatility vs the S&P 500) | 0.26 |
Price & events
Point at or tab to any week for its close.
Other perspectives
Council score for Reckitt Benckiser Group (RBGLY): perspectives
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Legends Council
6 lenses, 0 current
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Read on: Nov 16, 2026 · older than the 27 hours refresh window; not a current reading
Munger's Mindset
Balance Sheet & Valuation · historical
Read on: Nov 16, 2026 · older than the 27 hours refresh window; not a current reading
How to read these bars and different assessments
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.
On Nov 16, 2026, the Munger lens read the price at that time as fairly valued against its own estimate of value.
Readings on this page are from Nov 20, 2026, except a card that shows its own read date.
What is Reckitt Benckiser Group (RBGLY), and what does it report?
Short answer · as of
Reckitt is not merely a household-products manufacturer. Its portfolio combines cleaning and pest-control brands with pain relief, digestive remedies, sexual wellness and infant nutrition, so reported revenue reflects several distinct forms of recurring consumer demand.
Research dated 2026-09-12.
The group reports through Hygiene, Health and Nutrition, while RBGLY is an over-the-counter quotation for the United Kingdom parent. Consolidated figures therefore measure the broad brand portfolio rather than a narrow product franchise or a domestic American operator.
What do the latest results show for Reckitt Benckiser Group (RBGLY)?
Short answer · as of
The most recent reported quarter, Q2 FY2026, carried revenue of £6.46B. Against analyst estimates the company has EPS beat 3 of the last 8 reports.
Quarterly income statement — 4 quarters
| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q2 FY2026 | £6.46B | £657M | £0.20 (diluted) |
| Q4 FY2025 | £7.18B | £2.21B | £0.68 (diluted) |
| Q2 FY2025 | £6.98B | £958M | £0.28 (diluted) |
| Q4 FY2024 | £7.00B | £284M | £0.08 (diluted) |
What are the financial strengths and risks for Reckitt Benckiser Group (RBGLY)?
Short answer · as of
The distress and quality screens read Altman Z 2.51 · Piotroski F 5. Trailing ratios: ROE 42.9% · ROA 11.8% · current ratio 0.59 · earnings yield 7.7% · free-cash-flow yield 4.2%.
How is Reckitt Benckiser Group scored?
Research dated 2026-09-12.
Unlike a narrowly focused home-care peer, Reckitt combines surface hygiene, laundry care and pest control with consumer health, sexual wellness and infant nutrition. Demand is therefore spread across replenishment, self-care and nutrition occasions, but performance can diverge sharply among categories and regions.
RBGLY also differs from a domestic American consumer-staples listing: it is an over-the-counter quotation for a British parent. Institutional holdings reported through the American filing channel capture only a thin view of ownership and should not be treated as the shareholder base of the entire group.
| Company | Price | Market value | Score |
|---|---|---|---|
| $88.69 Nov 19, 2026 | $35.9B | — Model unavailable | |
| $14.96 Nov 19, 2026 | $48.2B | — Model unavailable | |
| $25.07 Nov 19, 2026 | $55.9B | — Model unavailable | |
| $45.59 Nov 19, 2026 | $50.9B | — Model unavailable | |
| $101.77 Nov 19, 2026 | $36.9B | — 5-pillar · not comparable | |
| $107.24 Nov 18, 2026 | $65.8B | — 5-pillar · not comparable | |
| $98.85 Nov 18, 2026 | $78.6B | — 5-pillar · not comparable | |
| $109.68 Nov 19, 2026 | $25.9B | — 5-pillar · not comparable | |
| $63.36 Nov 19, 2026 | $136B | — 5-pillar · not comparable | |
| $62.45 Nov 18, 2026 | $14.4B | — 5-pillar · not comparable | |
| $104.90 Nov 19, 2026 | $12.7B | — 5-pillar · not comparable | |
| $113.77 Nov 18, 2026 | $6.73B | — 5-pillar · not comparable |
The comparison model is unavailable. Other models are not directly comparable. Price and score dates are shown separately; market-value dates are unavailable.
The records behind this page
Who holds the shares?
Institutional ownership reported through 13F filings.
Tracked investors
Which of the 16 named investors we follow held RBGLY in their latest 13F filing, and what they did against the filing before it.
None of the 16 tracked investors reported RBGLY in their latest 13F filing.
How to read these figures
These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.
What has been published about Reckitt Benckiser Group (RBGLY)?
Common Questions About RBGLY (Consumer Defensive)
Research dated 2026-09-12; the full attribution is under Sources. The last question is answered from this page's own dated data, not from the research.
What does Reckitt sell besides Dettol and Lysol?
The portfolio includes Finish, Vanish and Air Wick in household care; Nurofen, Gaviscon and Strepsils in consumer health; Durex in sexual wellness; and Enfamil and Nutramigen in nutrition. These brands place Reckitt across Hygiene, Health and Nutrition rather than inside a narrow cleaning category.
What is Reckitt relying on for regional recovery?
Management expects broad emerging-market growth to continue, Europe to improve through execution, innovation and pricing, and North America to strengthen later in the reporting cycle. Progress against those regional claims is the most direct test of the maintained Core Reckitt outlook.
What is the RBGLY stock price today?
The last price recorded for Reckitt Benckiser Group plc (RBGLY), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.
Research written by Codex (gpt-5.6-sol) on 2026-09-12. AI-authored analysis; source dates are listed under Sources. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources: the source register lists the 17 figures on this page — 1 from SEC filings and earnings calls, 12 from Financial Modeling Prep (FMP) and 4 with no recorded source. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.
Publication details and research sources
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com